GeneDx Holdings Corp. (WGS)
66.65
+1.23
(+1.88%)
USD |
NASDAQ |
Apr 17, 12:01
GeneDx Holdings Cash from Investing (TTM) : -61.52M for Dec. 31, 2025
Cash from Investing (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash from Investing (TTM) Benchmarks
| Illumina, Inc. | -55.00M |
| Natera, Inc. | -132.21M |
| Guardant Health, Inc. | -627.20M |
| Delcath Systems, Inc. | -26.59M |
| CytoSorbents Corp. | -0.415M |